Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Auxiliary Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1070647A details a novel asymmetric synthesis for pseudophrynaminol. Discover cost reduction in API intermediate manufacturing and high-purity supply chain solutions.
Patent CN1028361C details asymmetric synthesis of 2(S)-glutaric acid intermediates, offering high purity and scalable routes for cardiovascular drug manufacturing.
Patent CN102477016B reveals asymmetric synthesis for Tapentadol intermediates. Achieve high chiral purity and cost reduction in pharmaceutical manufacturing.
Patent CN101935309B reveals a high-yield route for ezetimibe intermediates using a tricyclic indene oxazole auxiliary, offering superior stereoselectivity and cost-effective manufacturing solutions.
Discover a novel Brivaracetam synthesis method avoiding chiral columns. Enhanced purity, reduced costs, and scalable manufacturing for pharmaceutical intermediates.